The project with our partners from Vilnius University Life Sciences Center started in 2017 and is co-funded by European Union through Intelektas program. The goal is to design a phospholipid bilayer membrane-based sensor for detection of biological toxins in the acute bacterial infectious diseases diagnostics.
Drug encapsulation in macrophage-derived exosomes is a promising strategy in development of targeted delivery systems for treatment of aggressive and therapy-resistant cancer forms. These nanovesicles are naturally produced in human organism and can be applied as targeted delivery devices for treatment of oncological and other serious pathologies.